Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

ABTECT - Maintenance

ClinicalTrials.gov ID: NCT05535946

Public ClinicalTrials.gov record NCT05535946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106.

Study identification

NCT ID
NCT05535946
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abivax S.A.
Industry
Enrollment
1,116 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2023 (Actual)
Primary completion
Apr 28, 2026 (Actual)
Completion
May 2030 (Estimated)
Last update posted
Jul 7, 2026

2023 – 2030

United States locations

U.S. sites
72
U.S. states
29
U.S. cities
61
Facility City State ZIP Site status
Digestive Health Specialists of the Southeast Dothan Alabama 36305 —
Research Solutions of Arizona, PC Litchfield Park Arizona 85340 —
GI Alliance Sun City Arizona 85351 —
University of Arizona Tucson Arizona 85724 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205-7199 —
Citrus Valley Gastroenterology Covina California 91723 —
University of California (San Diego) La Jolla California 92093 —
United Medical Doctors Murrieta California 92563 —
California Medical Research Associates Inc. Northridge California 91324 —
Clinnova Research Solutions Orange California 92868 —
Clinical Applications Laboratories San Diego California 92103 —
Kaiser Foundation Research Institute, a Division of Kaiser Permanente Hospitals Aurora Colorado 80014 —
Danbury Hospital Danbury Connecticut 06810 —
West Central Gastroenterology d/b/a Gastro Florida Clearwater Florida 33762 —
Nature Coast Clinical Research, LLC Inverness Florida 34452 —
Auzmer Research Lakeland Florida 33813 —
Infinite Clinical Research Inc Miami Florida 33133 —
Research Associates of South Florida, LLC Miami Florida 33134 —
University of Miami Miami Florida 33136 —
MedOne Clinical Research LLC Miami Florida 33145 —
Nicklaus Children's Hospital Miami Florida 33155-3009 —
Medical Professional Clinical Research Center Miami Florida 33165 —
Wellness Clinical Research Miami Lakes Florida 33016 —
Ocala GI Research Ocala Florida 34471 —
Arnold Palmer Hospital For Children Orlando Florida 32806 —
Advanced Research Institute, Inc. Orlando Florida 32825 —
GCP Clinical Research, LLC Tampa Florida 33609 —
Guardian Angel Research Center Tampa Florida 33614 —
Alliance Clinical Research Tampa Florida 33615 —
Atlanta Center for Gastroenterology, P.C. Decatur Georgia 30033 —
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
University of Chicago Medical Center Chicago Illinois 60637 —
GI Alliance Gurnee Illinois 60031 —
Iowa Digestive Disease Center Clive Iowa 50325 —
The University of Iowa Iowa City Iowa 52242 —
University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas 66160 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Boston Medical Center Boston Massachusetts 02118 —
Lucida Clinical Trials LLC New Bedford Massachusetts 02740 —
Henry Ford Hospital Sterling Heights Michigan 48313 —
Digestive Health Center PA Ocean Springs Mississippi 39564 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 —
AIG Digestive Disease Research Florham Park New Jersey 07932 —
Mount Sinai New York New York 10029 —
Rochester Clinical Research Rochester New York 14609 —
Charlotte Gastroenterology and Hepatology, P.L.L.C Charlotte North Carolina 28207 —
Wilmington Health Wilmington North Carolina 28401 —
Wake Forest Baptist Winston-Salem North Carolina 27157 —
Wexner Medical Center Columbus Ohio 43210 —
Board of Regents of the University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
UPMC Pittsburgh Pennsylvania 15213 —
Frontier Clinical Research, LLC Uniontown Pennsylvania 15401 —
Columbia Digestive Health Research Columbia South Carolina 29204 —
Gastroenterology Associates, PA Greenville South Carolina 29607 —
Rapid City Medical Center, LLC Rapid City South Dakota 57701 —
Gastroenterology Center of the MidSouth PC Germantown Tennessee 38138 —
Central Texas Clinical Research, LLC Austin Texas 78705 —
Inquest Clinical Research Baytown Texas 77521 —
Texas Digestive Disease Consultants Cedar Park Texas 78613 —
Baylor Scott and White Dallas Texas 75246 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Baylor College Of Medicine Houston Texas 77030 —
Houston Methodist Hospital Houston Texas 77030 —
Biopharma Informatic, LLC Houston Texas 77084 —
GI Alliance - Southlake Southlake Texas 76092 —
Tyler Research Institute, LLC Tyler Texas 75701 —
Care Access Research LLC Ogden Utah 84403 —
University of Utah Salt Lake City Utah 84112 —
Gastroenterology Associates of Tidewater Chesapeake Virginia 23320 —
Gastroenterology Consultants and Endoscopy Center of Southwest Virginia Roanoke Virginia 24014 —
TPMG Clinical Research Williamsburg Williamsburg Virginia 23188 —
The Vancouver Clinic Vancouver Washington 98664 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 341 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05535946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05535946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →